Blog Archive

Friday, March 5, 2021

11 Stocks Moving In Thursday's After-Hours Session

 11 Stocks Moving In Thursday's After-Hours Session

Article Tools

Companies Mentioned

SymbolLastChange
ACOR$6.780.00%
AVGO$443.590.00%
CLGX$81.790.00%
CSGP$758.460.00%
EVFM$3.270.00%
View All Mentioned

11 Stocks Moving In Thursday's After-Hours Session

3/4/21 5:44 PM ET (Benzinga)Print

Gainers

  • Ocular Therapeutics (NASDAQ: OCUL) shares are trading higher after the company announced the supplemental New Drug Application for DEXTENZA 0.4 mg for intracanalicular use has been accepted for review by the FDA.
  • CoStar Group (NASDAQ: CSGP) shares are trading higher after the company announced it withdrew its bid to acquire CoreLogic.
  • Fulgent Genetics (NASDAQ: FLGT) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS guidance above estimates.
  • Waitr Holdings (NASDAQ: WTRH) share are trading higher after the company announced it agreed to pursue a partnership with Flow Payments to create a compliant marketplace, delivery and payment solution for dispensaries selling cannabis.
  • Senseonics (NYSE: SENS) shares are trading higher after the company reported better-than-expected Q4 sales results.

Losers

  • CoreLogic (NYSE: CLGX) shares are trading lower after CoStar Group announced it withdrew its bid to acquire the company.
  • Gap (NYSE: GPS) shares are trading lower after the company reported worse-than-expected Q4 sales results.
  • Broadcom (NASDAQ: AVGO) shares are trading lower after the company reported Q1 earnings results.
  • Medallia (NYSE: MDLA) shares are trading lower after the company announced inline Q4 EPS results and issued Q1 2021 revenue guidance below estimates. The company also announced it plans to acquire Decibel.
  • Evofem Biosciences (NASDAQ: EVFM) shares are trading lower after the company reported worse-than-expected Q4 EPS results.
  • Acorda Therapeutics (NASDAQ: ACOR) shares are trading lower after the company reported worse-than-expected Q4 EPS results.

No comments:

Post a Comment

SGNX

 

Labels